Literature DB >> 9238831

Fc epsilon RI-expressing antigen-presenting cells: new players in the atopic game.

T Bieber1.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9238831     DOI： 10.1016/s0167-5699(97)01046-3

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


× No keyword cloud information.
  12 in total

1.  The high-affinity IgE receptor (FcepsilonRI) blocks apoptosis in normal human monocytes.

Authors:  N Katoh; S Kraft; J H Wessendorf; T Bieber
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

2.  The inhibition of cutaneous T cell apoptosis may prevent resolution of inflammation in atopic eczema.

Authors:  C H Orteu; M H Rustin; E O'Toole; C Sabin; M Salmon; L W Poulter; A N Akbar
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

3.  Evidence for a differential expression of the FcepsilonRIgamma chain in dendritic cells of atopic and nonatopic donors.

Authors:  Natalija Novak; Carmen Tepel; Susanne Koch; Klaudia Brix; Thomas Bieber; Stefan Kraft
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

Review 4.  Animal models for IgE-meditated cancer immunotherapy.

Authors:  Tracy R Daniels; Otoniel Martínez-Maza; Manuel L Penichet
Journal:  Cancer Immunol Immunother       Date:  2011-12-23       Impact factor: 6.968

Review 5.  [Specific immunotherapy in the treatment of atopic dermatitis].

Authors:  M Niebuhr; A Kapp; T Werfel
Journal:  Hautarzt       Date:  2007-03       Impact factor: 0.751

Review 6.  Immunological Pathomechanisms of Spongiotic Dermatitis in Skin Lesions of Atopic Dermatitis.

Authors:  Ryoji Tanei; Yasuko Hasegawa
Journal:  Int J Mol Sci       Date:  2022-06-15       Impact factor: 6.208

Review 7.  [Specific immunotherapy (SIT) in atopic dermatitis and food allergy].

Authors:  M Niebuhr; A Kapp; T Werfel
Journal:  Hautarzt       Date:  2008-07       Impact factor: 0.751

Review 8.  Why is the prevalence of allergic diseases increasing? A critical assessment of some classical risk factors.

Authors:  D Charpin; M Gouitaa
Journal:  Mediators Inflamm       Date:  2001-12       Impact factor: 4.711

Review 9.  Immunoglobulin E-bearing antigen-presenting cells in atopic dermatitis.

Authors:  Natalija Novak; Thomas Bieber; Stefan Kraft
Journal:  Curr Allergy Asthma Rep       Date:  2004-07       Impact factor: 4.919

Review 10.  Cellular aspects of atopic dermatitis.

Authors:  Liang-Shiou Ou; Jing-Long Huang
Journal:  Clin Rev Allergy Immunol       Date:  2007-12       Impact factor: 10.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.